Title : Erratum: Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum].

Pub. Date : 2021

PMID : 33603341






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Erratum: Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting beta2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]. Formoterol Fumarate ATPase H+ transporting V0 subunit a2 Homo sapiens